CD83 and ovarian cancer: The intersection of the transcriptome (fold change ≥2) and proteome (fold change ≥1.5) included 83 differentially-expressed (DE) targets between CD83-KD and NC ovarian cancer cells, whereas OV-vs.-NC showed only two DE targets (CD83 and RSPH4A) (Figure 4d).